A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

Clinical trial NCT02851277 · COMPLETED

Trial details

NCT number

NCT02851277

Sponsor

Astellas Pharma Global Development, Inc.

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2016-12-13

Primary completion

2018-12-06

Enrollment

31

View on ClinicalTrials.gov